Affimed is leading efforts to engage natural killer (NK) cells and macrophages to kill cancer cells. Having translated antibody engineering capabilities into clinical-phase candidates, Affimed has ...

Electrical Currents May Make Body's Cancer-Killing Cells Even Better Killers July 25, 2024 — Scientists have discovered that electrical currents may make Natural Killer (NK) cells -- our very ...

may lead to greater tumor kill by increasing the frequency of alloreactive NK cells. Allogeneic NK cell therapy: moving beyond autologous transfer Hypothesis that autologous NK cells may be ...

Following the discovery of inhibitory KIR and the understanding that they play a role in preventing NK cell killing of self MHC I-expressing tumor cells, investigators began to research the ...

CAR-NK therapy involves modifying NK cells using advanced chimeric antigen receptor (CAR) technology, leveraging their broad tumor-killing capabilities and unique mechanisms for recognizing target ...

Researchers discovered that severe COVID infection causes the body to produce a special type of monocyte with anti-cancer ...

MDNA11 shows significant survival benefits in preclinical glioblastoma models, expanding CD8 + T and NK cells Bizaxofusp selectively targets human tumor cells and immune-suppressive cells, enhancing ...

The study also showed that the RNA in the COVID-19 virus could incite the production of new immune cells that target and ...